HemoglobinA1c Is a Risk Factor for Changes of Bone Mineral Density: A Mendelian Randomization Study

BackgroundAs a valuable blood glucose measurement, HemoglobinA1c (HbA1c) is of great clinical value for diabetes. However, in previous observational studies, studies on its effect on bone mineral density (BMD) have different results. This study aimed to use Mendelian randomization (MR) to assess the...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Xiaoxiao Ji, Jianqiao Hong, Zihao Qu, Weinan Yang, Yibo Wang, Jiyan Lin, Congsun Li, Jie Wang, Haochen Mou, Mingmin Shi, Chenhe Zhou, Wei Wang, Changjian Lin, Shigui Yan, Haobo Wu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2022-07-01
Saila:	Frontiers in Endocrinology
Gaiak:	bone mineral density hemoglobinA1c hemoglobin mendelian randomization osteoporosis
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fendo.2022.942878/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!